Loading...
8 Malaysia Device Drug Combination Reports
Country Covered: Malaysia
Study Period: 2018- 2028
Major Players: Medtronic, Roche, NovoNordisk, Abbott, Dexcom
Country Covered: Malaysia
Study Period: 2017- 2028
Major Players: F. Hoffmann-La Roche AG, Medtronic PLC, Abbott Diabetes Care, Novo Nordisk A/S, Eli Lilly and Company
Country Covered: Malaysia
Study Period: 2017- 2028
Major Players: Novo Nordisk, Medtronic, Sanofi, Eli Lilly and Company, Ypsomed Holding
Country Covered: Malaysia
Study Period: 2017- 2028
Major Players: Biocon, Wockhardt, Novo Nordisk A/S, Eli Lilly and Company, Sanofi Aventis
Country Covered: Malaysia
Study Period: 2018 - 2028
Major Players: Novo Nordisk, Medtronic, Sanofi, Ypsomed, Eli Lilly and Company
Country Covered: Malaysia
Study Period: 2018 - 2028
Major Players: Medtronic plc, F. Hoffmann-La Roche AG, Novo Nordisk A/S, Abbott Laboratories, DexCom, Inc.
Country Covered: Malaysia
Study Period: 2018 - 2028
Major Players: Novo Nordisk, Sanofi, Eli Lilly, Biocon
Country Covered: Malaysia
Study Period: 2017- 2028
Major Players: Novo Nordisk, Sanofi, El lilly, Medtronics, Roche